Thousands of men with prostate cancer are set to get a life-extending drug on the NHS within weeks – in a breakthrough that could give families precious extra years together. For the first time, ...

Add Yahoo as a preferred source to see more of our stories on Google. A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth ...

Add Yahoo as a preferred source to see more of our stories on Google. A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, experts have said. The treatment, a ...

A major study of nearly 19,000 men has found that a baldness drug significantly cut the risk of prostate cancer, but its side effects may keep many from using it to prevent what has become the second ...

Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Those with prostate cancer that returns after surgery or radiation—and ...

A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn't spread. In ...

A new model that compares costs and outcomes of drugs used in the treatment of castrate-resistant prostate cancer has concluded that generic docetaxel and abiraterone (Zytiga) offer better value than ...

Sir Chris Hoy was diagnosed with stage four prostate cancer in 2023 and has now shared a positive health update, saying he is ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...